Back to search

Article

Loss of E-cadherin enhances IGF1-IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R inhibitors

2018-01-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Insulin-like growth factor I (IGF1) signaling regulates breast cancer initiation and progression and associated cancer phenotypes. We previously identified E-cadherin (CDH1) as a repressor of IGF1 signaling and in this study examined how loss of E-cadherin affects IGF1R signaling and response to anti-IGF1R therapies in breast cancer. <h4>Experimental Design</h4> Breast cance...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
752252f6-ce35-54f0-b729-f0fa5dad512e
DOI
10.1101/253278
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Loss of E-cadherin enhances IGF1-IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R inhibitorsDOI 10.1101/253278
Select a neighboring publication to make it the new centre.